This site is intended for healthcare professionals only

COVID-19: New technology to help identify those at high risk

Written by: | Published:

The new assessment looks at more factors The new assessment looks at more factors than previously

New technology has been introduced in England to help clinicians identify a new group of people who may be at high risk from COVID-19 for the first time.

Over 800,000 adults will now be prioritised to receive a vaccine as part of the current vaccination cohorts. The technology analyses a combination of risk factors based on medical records, to assess whether somebody may be more vulnerable than was previously understood, helping clinicians provide vaccination more quickly to them and ensuring patients can benefit from additional advice and support.

‘For the first time, we are able to go even further in protecting the most vulnerable in our communities,’ said Deputy Chief Medical Officer for England Dr Jenny Harries.

‘This new model is a tribute to our health and technology researchers. The model’s data-driven approach to medical risk assessment will help the NHS identify further individuals who may be at high risk from COVID-19 due to a combination of personal and health factors. This action ensures those most vulnerable to COVID-19 can benefit from both the protection that vaccines provide, and from enhanced advice, including shielding and support, if they choose it.’

Read more: NHS patients to receive get life-saving treatment

The move comes as it was announced that an extra 1.7 million people are expected to be added to the 2.3 million already on the list. This group will be sent a letter from NHS England in the coming days explaining that their risk factors may help identify them as high clinical risk and that they are included within the support and advice for the clinically extremely vulnerable. They will be invited to receive a COVID-19 vaccine as soon as possible if they have not already had the jab, and will be given advice on precautionary measures, including shielding where this is current advice.

Read more: Frontline workers left ‘risking lives to provide treatment’

‘The BMA has long highlighted the fact that people from an ethnic minority background, especially with underlying conditions, are at high risk of death from COVID-19 and that those from poorer areas are also twice as likely to die from this terrible disease. Both of these groups are now included in this new QCovid risk tool,’ said BMA council chair Dr Chaand Nagpaul.

‘Many of these patients fall outside of the current JCVI priority groups for the Covid vaccine and so it is now vitally important that these patients are prioritised for vaccination and urgently protected against the deadly effects of COVID-19.’

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.



Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code

Read a free issue from Practice Nursing

Register to read a free issue from our sister publication, Practice Nursing.

Including articles on asthma, diabetes and more. Read your copy.


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.